B-Cancer	0	6	Cancer	Cancer	NN	B-NP
O	7	18	progression	progression	NN	I-NP
O	19	22	and	and	CC	I-NP
O	23	26	p53	p53	NN	I-NP
O	26	27	.	.	.	O

O	29	31	In	In	IN	B-PP
O	32	33	a	a	DT	B-NP
O	34	41	complex	complex	JJ	I-NP
O	42	50	organism	organism	NN	I-NP
O	50	51	,	,	,	O
B-Cell	52	59	somatic	somatic	JJ	B-NP
I-Cell	60	65	cells	cell	NNS	I-NP
O	66	69	are	be	VBP	B-VP
O	70	75	under	under	IN	B-PP
O	76	88	intermittent	intermittent	JJ	B-NP
O	89	98	selection	selection	NN	I-NP
O	99	107	pressure	pressure	NN	I-NP
O	108	111	for	for	IN	B-PP
O	112	115	the	the	DT	B-NP
O	116	125	emergence	emergence	NN	I-NP
O	126	128	of	of	IN	B-PP
O	129	136	mutants	mutant	NNS	B-NP
O	137	141	that	that	WDT	B-NP
O	142	145	can	can	MD	B-VP
O	146	153	survive	survive	VB	I-VP
O	154	167	environmental	environmental	JJ	B-NP
O	168	175	insults	insult	NNS	I-NP
O	176	179	and	and	CC	O
O	180	184	that	that	WDT	B-NP
O	185	188	can	can	MD	B-VP
O	189	193	grow	grow	VB	I-VP
O	194	206	autonomously	autonomously	RB	B-ADVP
O	207	214	despite	despite	IN	B-PP
O	215	222	adverse	adverse	JJ	B-NP
O	223	233	conditions	condition	NNS	I-NP
O	233	234	.	.	.	O

O	235	243	Repeated	Repeat	VBN	B-NP
O	244	250	rounds	round	NNS	I-NP
O	251	253	of	of	IN	B-PP
O	254	262	mutation	mutation	NN	B-NP
O	262	263	,	,	,	O
O	264	273	selection	selection	NN	B-NP
O	273	274	,	,	,	O
O	275	278	and	and	CC	O
O	279	292	proliferation	proliferation	NN	B-NP
O	293	296	may	may	MD	B-VP
O	297	301	lead	lead	VB	I-VP
O	302	304	to	to	TO	B-PP
B-Cancer	305	311	cancer	cancer	NN	B-NP
O	311	312	.	.	.	O

O	313	316	The	The	DT	B-NP
O	317	325	organism	organism	NN	I-NP
O	326	334	prevents	prevent	VBZ	B-VP
O	335	344	malignant	malignant	JJ	B-NP
O	345	359	transformation	transformation	NN	I-NP
O	360	362	by	by	IN	B-PP
O	363	371	assuring	assure	VBG	B-VP
O	372	380	accurate	accurate	JJ	B-NP
O	381	384	DNA	DNA	NN	I-NP
O	385	391	repair	repair	NN	I-NP
O	392	398	before	before	IN	B-PP
B-Cell	399	403	cell	cell	NN	B-NP
O	404	412	division	division	NN	I-NP
O	412	413	,	,	,	O
O	414	416	by	by	IN	B-PP
O	417	424	forcing	force	VBG	B-VP
O	425	428	the	the	DT	B-NP
O	429	434	death	death	NN	I-NP
O	435	437	of	of	IN	B-PP
B-Cell	438	443	cells	cell	NNS	B-NP
O	444	448	with	with	IN	B-PP
O	449	458	excessive	excessive	JJ	B-NP
O	459	462	DNA	DNA	NN	I-NP
O	463	469	damage	damage	NN	I-NP
O	469	470	,	,	,	O
O	471	474	and	and	CC	O
O	475	477	by	by	IN	B-PP
O	478	485	placing	place	VBG	B-VP
O	486	492	limits	limit	NNS	B-NP
O	493	495	on	on	IN	B-PP
O	496	499	the	the	DT	B-NP
O	500	511	replicative	replicative	JJ	I-NP
O	512	521	lifespans	lifespan	NNS	I-NP
O	522	524	of	of	IN	B-PP
O	525	529	most	most	JJS	B-NP
B-Cell	530	537	somatic	somatic	JJ	I-NP
I-Cell	538	543	cells	cell	NNS	I-NP
O	543	544	.	.	.	O

O	545	548	The	The	DT	B-NP
O	549	552	p53	p53	NN	I-NP
O	553	557	gene	gene	NN	I-NP
O	558	560	is	be	VBZ	B-VP
O	561	562	a	a	DT	B-NP
O	563	564	"	"	``	I-NP
O	564	572	guardian	guardian	JJ	I-NP
O	573	575	of	of	IN	B-PP
O	576	579	the	the	DT	B-NP
O	580	586	genome	genome	NN	I-NP
O	586	587	"	"	``	O
O	587	588	-	-	HYPH	O
O	588	589	-	-	HYPH	O
O	589	591	it	it	PRP	B-NP
O	592	601	regulates	regulate	VBZ	B-VP
O	602	610	multiple	multiple	JJ	B-NP
O	611	621	components	component	NNS	I-NP
O	622	624	of	of	IN	B-PP
O	625	628	the	the	DT	B-NP
O	629	632	DNA	DNA	NN	I-NP
O	633	639	damage	damage	NN	I-NP
O	640	647	control	control	NN	I-NP
O	648	656	response	response	NN	I-NP
O	657	660	and	and	CC	O
O	661	669	promotes	promote	VBZ	B-VP
B-Cell	670	678	cellular	cellular	JJ	B-NP
O	679	689	senescence	senescence	NN	I-NP
O	689	690	.	.	.	O

O	691	700	Disabling	Disable	VBG	B-VP
O	701	710	mutations	mutation	NNS	B-NP
O	711	714	and	and	CC	I-NP
O	715	724	deletions	deletion	NNS	I-NP
O	725	727	of	of	IN	B-PP
O	728	731	p53	p53	NN	B-NP
O	732	737	occur	occur	VBP	B-VP
O	738	740	in	in	IN	B-PP
O	741	743	50	50	CD	B-NP
O	743	744	%	%	NN	I-NP
O	745	747	of	of	IN	B-PP
O	748	753	human	human	JJ	B-NP
B-Cancer	754	761	tumours	tumour	NNS	I-NP
O	761	762	.	.	.	O

B-Cancer	763	766	p53	p53	NN	B-NP
I-Cancer	766	767	-	-	HYPH	I-NP
I-Cancer	767	776	deficient	deficient	JJ	I-NP
I-Cancer	777	784	cancers	cancer	NNS	I-NP
O	785	788	are	be	VBP	B-VP
O	789	794	often	often	RB	B-ADVP
O	795	803	unstable	unstable	JJ	B-ADJP
O	803	804	,	,	,	O
O	805	815	aggressive	aggressive	JJ	B-ADJP
O	815	816	,	,	,	O
O	817	820	and	and	CC	O
O	821	830	resistant	resistant	JJ	B-ADJP
O	831	833	to	to	TO	B-PP
O	834	841	therapy	therapy	NN	B-NP
O	841	842	.	.	.	O

